 Nicolas Busquet
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy, Temporal Lobe | 2 | 2024 | 38 | 0.420 |
Why?
| | Calcium Channels, T-Type | 2 | 2022 | 96 | 0.300 |
Why?
| | Down Syndrome | 3 | 2023 | 496 | 0.300 |
Why?
| | Spatial Memory | 2 | 2024 | 26 | 0.280 |
Why?
| | Seizures | 3 | 2024 | 426 | 0.250 |
Why?
| | Nanomedicine | 1 | 2025 | 47 | 0.230 |
Why?
| | Complement Inactivating Agents | 1 | 2025 | 63 | 0.220 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 151 | 0.210 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2024 | 51 | 0.210 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4295 | 0.210 |
Why?
| | Phenotype | 3 | 2024 | 3196 | 0.210 |
Why?
| | Binge Drinking | 1 | 2023 | 43 | 0.210 |
Why?
| | Ethanol | 2 | 2025 | 608 | 0.210 |
Why?
| | Glycine | 1 | 2024 | 176 | 0.200 |
Why?
| | Nanoparticles | 2 | 2025 | 481 | 0.190 |
Why?
| | Genetic Background | 1 | 2021 | 11 | 0.190 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 135 | 0.180 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.180 |
Why?
| | Pyrazoles | 1 | 2024 | 423 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.180 |
Why?
| | Conditioning, Classical | 1 | 2021 | 103 | 0.170 |
Why?
| | Mice | 12 | 2025 | 17787 | 0.170 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2020 | 37 | 0.160 |
Why?
| | Action Potentials | 2 | 2022 | 493 | 0.150 |
Why?
| | Potassium Channels | 1 | 2020 | 151 | 0.150 |
Why?
| | Epilepsy | 1 | 2023 | 333 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.150 |
Why?
| | Hippocampus | 4 | 2025 | 895 | 0.140 |
Why?
| | Lateral Ventricles | 1 | 2018 | 35 | 0.140 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 61 | 0.140 |
Why?
| | Animals | 15 | 2025 | 36940 | 0.140 |
Why?
| | Ventral Tegmental Area | 1 | 2018 | 58 | 0.140 |
Why?
| | Animals, Newborn | 3 | 2024 | 844 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2020 | 266 | 0.130 |
Why?
| | Axons | 1 | 2018 | 198 | 0.120 |
Why?
| | Myelin Sheath | 1 | 2018 | 167 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 842 | 0.120 |
Why?
| | Aging | 1 | 2025 | 1864 | 0.110 |
Why?
| | Brain Injuries | 1 | 2020 | 494 | 0.110 |
Why?
| | Behavior, Animal | 1 | 2018 | 501 | 0.110 |
Why?
| | Gene Dosage | 1 | 2014 | 140 | 0.110 |
Why?
| | Fertility | 1 | 2014 | 160 | 0.100 |
Why?
| | Neurons | 2 | 2023 | 1590 | 0.100 |
Why?
| | Maze Learning | 2 | 2024 | 103 | 0.100 |
Why?
| | Galantamine | 1 | 2011 | 2 | 0.090 |
Why?
| | Brain | 3 | 2024 | 2668 | 0.090 |
Why?
| | Association Learning | 1 | 2011 | 61 | 0.090 |
Why?
| | Rats | 3 | 2025 | 5647 | 0.080 |
Why?
| | Biological Evolution | 1 | 2014 | 474 | 0.080 |
Why?
| | Odorants | 2 | 2011 | 109 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2167 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2486 | 0.060 |
Why?
| | Pilocarpine | 1 | 2024 | 15 | 0.060 |
Why?
| | Smell | 1 | 2005 | 117 | 0.060 |
Why?
| | Dogs | 1 | 2025 | 413 | 0.050 |
Why?
| | Choice Behavior | 1 | 2005 | 170 | 0.050 |
Why?
| | Nitriles | 1 | 2024 | 172 | 0.050 |
Why?
| | Inflammasomes | 1 | 2025 | 131 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2023 | 3015 | 0.050 |
Why?
| | Cognition | 2 | 2023 | 1153 | 0.050 |
Why?
| | Doxorubicin | 1 | 2025 | 362 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 52 | 0.050 |
Why?
| | Hydrocephalus | 1 | 2024 | 106 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2024 | 206 | 0.050 |
Why?
| | Microglia | 1 | 2025 | 251 | 0.050 |
Why?
| | Electroencephalography | 1 | 2024 | 423 | 0.050 |
Why?
| | Complement Activation | 1 | 2025 | 415 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 202 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2021 | 200 | 0.040 |
Why?
| | Pyrimidines | 1 | 2024 | 470 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 305 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1759 | 0.040 |
Why?
| | Neuronal Plasticity | 1 | 2022 | 290 | 0.040 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 641 | 0.040 |
Why?
| | Neuroprotection | 1 | 2020 | 42 | 0.040 |
Why?
| | Aminopyridines | 1 | 2020 | 98 | 0.040 |
Why?
| | Hand Strength | 1 | 2020 | 123 | 0.040 |
Why?
| | Male | 6 | 2024 | 67762 | 0.040 |
Why?
| | Motor Skills | 1 | 2020 | 97 | 0.040 |
Why?
| | Neuroprotective Agents | 1 | 2020 | 131 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 19 | 0.040 |
Why?
| | Carotid Arteries | 1 | 2020 | 206 | 0.040 |
Why?
| | Fear | 1 | 2021 | 338 | 0.040 |
Why?
| | Dizocilpine Maleate | 1 | 2018 | 22 | 0.040 |
Why?
| | Female | 6 | 2025 | 73304 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 78 | 0.040 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2018 | 20 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2018 | 100 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2020 | 217 | 0.030 |
Why?
| | Calcium Channel Blockers | 1 | 2018 | 167 | 0.030 |
Why?
| | Calcium | 1 | 2022 | 1199 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 390 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2021 | 762 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 303 | 0.030 |
Why?
| | Hyperkinesis | 1 | 2014 | 16 | 0.030 |
Why?
| | Calorimetry, Indirect | 1 | 2014 | 84 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 118 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 314 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 477 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 515 | 0.030 |
Why?
| | Motor Activity | 1 | 2018 | 718 | 0.030 |
Why?
| | Mutation | 1 | 2024 | 3958 | 0.020 |
Why?
| | Hypoxia | 1 | 2020 | 1112 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 861 | 0.020 |
Why?
| | Nootropic Agents | 1 | 2011 | 27 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2011 | 269 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2011 | 298 | 0.020 |
Why?
| | Trisomy | 1 | 2011 | 80 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2475 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 2892 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1774 | 0.020 |
Why?
| | Liver | 1 | 2014 | 1943 | 0.020 |
Why?
| | Blood Glucose | 1 | 2014 | 2186 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 585 | 0.010 |
Why?
| | Humans | 2 | 2025 | 137585 | 0.010 |
Why?
|
|
Busquet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|